These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15567923)

  • 1. Chronic allograft nephropathy. A multiple approach to target nonimmunological factors.
    Ruggenenti P
    Contrib Nephrol; 2005; 146():87-94. PubMed ID: 15567923
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic renal allograft dysfunction (CAD): new frontiers. Introduction.
    Sayegh MH
    Kidney Int Suppl; 2010 Dec; (119):S1. PubMed ID: 21116309
    [No Abstract]   [Full Text] [Related]  

  • 3. Renin-angiotensin system in chronic renal allograft dysfunction.
    Shihab FS
    Contrib Nephrol; 2001; (135):222-34. PubMed ID: 11705287
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chronic rejection and chronic allograft nephropathy].
    Sugiyama S
    Nihon Jinzo Gakkai Shi; 2004 Oct; 46(7):667-75. PubMed ID: 15570894
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of transforming growth factor beta in chronic renal allograft nephropathy.
    Jain S; Furness PN; Nicholson ML
    Transplantation; 2000 May; 69(9):1759-66. PubMed ID: 10830203
    [No Abstract]   [Full Text] [Related]  

  • 6. The natural history of chronic allograft nephropathy.
    Nankivell BJ; Borrows RJ; Fung CL; O'Connell PJ; Allen RD; Chapman JR
    N Engl J Med; 2003 Dec; 349(24):2326-33. PubMed ID: 14668458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infection and chronic allograft dysfunction.
    Dupont PJ; Manuel O; Pascual M
    Kidney Int Suppl; 2010 Dec; (119):S47-53. PubMed ID: 21116318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rescue therapy with tacrolimus and mycophenolate mofetil does not prevent deterioration of graft function in C4d-positive chronic allograft nephropathy.
    Schwarz C; Regele H; Huttary N; Wahrmann M; Exner M; Nagy-Bojarsky K; Kletzmayr J; Hörl WH; Böhmig GA
    Wien Klin Wochenschr; 2006 Jul; 118(13-14):397-404. PubMed ID: 16865644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consequences of transplant quality on chronic allograft nephropathy.
    Timsit MO; Yuan X; Floerchinger B; Ge X; Tullius SG
    Kidney Int Suppl; 2010 Dec; (119):S54-8. PubMed ID: 21116319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rejection and function and chronic allograft dysfunction.
    de Fijter JW
    Kidney Int Suppl; 2010 Dec; (119):S38-41. PubMed ID: 21116316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.
    Khalkhali HR; Ghafari A; Hajizadeh E; Kazemnejad A
    Exp Clin Transplant; 2010 Dec; 8(4):277-82. PubMed ID: 21143092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of renal damage in chronic rejection.
    Ponticelli C
    Kidney Int Suppl; 2000 Apr; 75():S62-70. PubMed ID: 10828764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic allograft nephropathy categorised in chronic interstitial and vascular rejection.
    Sijpkens YW; Bruijn JA; Paul LC
    Transplant Proc; 2001; 33(1-2):1153. PubMed ID: 11267233
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic allograft nephropathy.
    Najafian B; Kasiske BL
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):149-55. PubMed ID: 18277147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of aspirin on early allograft thrombosis and chronic allograft nephropathy following renal transplantation.
    Murphy GJ; Taha R; Windmill DC; Metcalfe M; Nicholson ML
    Br J Surg; 2001 Feb; 88(2):261-6. PubMed ID: 11167878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive treatment and progression of histologic lesions in kidney allografts.
    Morales JM
    Kidney Int Suppl; 2005 Dec; (99):S124-30. PubMed ID: 16336565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic allograft nephropathy: the inevitable outcome of renal transplantation?
    Dodd SM
    Curr Top Pathol; 1999; 92():37-60. PubMed ID: 9919806
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantitation of allograft fibrosis and chronic allograft nephropathy.
    Grimm PC; Nickerson P; Gough J; McKenna R; Jeffery J; Birk P; Rush DN
    Pediatr Transplant; 1999 Nov; 3(4):257-70. PubMed ID: 10562970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights in chronic allograft rejection.
    Paul LC
    Curr Opin Urol; 2002 Mar; 12(2):89-93. PubMed ID: 11859253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Case of Very Early Kidney Allograft Dysfunction.
    Udomkarnjananun S; Srijaruneruang S; Townamchai N; Iampenkhae K; Taesombat W; Avihingsanon Y; Praditpornsilpa K
    Am J Kidney Dis; 2019 Jun; 73(6):A10-A14. PubMed ID: 31126414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.